Invention Grant
- Patent Title: Heteroaryl-substituted sulfonamide compounds and their use as sodium channel inhibitors
-
Application No.: US16555983Application Date: 2019-08-29
-
Publication No.: US10752623B2Publication Date: 2020-08-25
- Inventor: Jean-Christophe Andrez , Kristen Nicole Burford , Christoph Martin Dehnhardt , Thilo Focken , Michael Edward Grimwood , Qi Jia , Verner Alexander Lofstrand , Steven Sigmund Wesolowski , Michael Scott Wilson
- Applicant: Xenon Pharmaceuticals Inc.
- Applicant Address: CA Burnaby
- Assignee: Xenon Pharmaceuticals Inc.
- Current Assignee: Xenon Pharmaceuticals Inc.
- Current Assignee Address: CA Burnaby
- Agency: Fish & Richardson P.C.
- Main IPC: C07D417/14
- IPC: C07D417/14 ; A61P25/08 ; C07C53/18 ; C07D401/14 ; C07D409/14
Abstract:
This invention is directed to heteroaryl-substituted sulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy.
Public/Granted literature
- US20200071313A1 HETEROARYL-SUBSTITUTED SULFONAMIDE COMPOUNDS AND THEIR USE AS SODIUM CHANNEL INHIBITORS Public/Granted day:2020-03-05
Information query
